Similar articles

• Significance of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG) in patients with breast, gastric and colorectal cancer.

  Shimizu Y, Oshima K, Nakano Y, Fujita M, Taguchi T. Shimizu Y, et al. Biken J. 1981 Sep;24(3):95-102. Biken J. 1981. PMID: 6175310
• Detection of mammary micrometastases by pregnancy-associated alpha 2-glycoprotein (PAG, alpha 2-PAG or PAM) and carcinoembryonic antigen (CEA).

  Anderson JM, Stimson WH, Gettinby G, Jhunjhunwala SK, Burt RW. Anderson JM, et al. Eur J Cancer (1965). 1979 May;15(5):709-14. doi: 10.1016/0014-2964(79)90145-2. Eur J Cancer (1965). 1979. PMID: 510333 No abstract available.
• Pregnancy-associated plasma protein A and extensive necrosis. Clinically significant predictors of early recurrence in stage I estrogen receptor-negative breast carcinoma.

  Kuhajda FP, Eggleston JC. Kuhajda FP, et al. Lab Invest. 1985 Jul;53(1):101-7. Lab Invest. 1985. PMID: 2409349
• Carcinoembryonic antigen in patients with breast or colon cancer.

  Lee YN. Lee YN. West J Med. 1978 Nov;129(5):374-80. West J Med. 1978. PMID: 364839 Free PMC article. Review.
• [Human breast cancer markers].

  Remennik LV. Remennik LV. Eksp Onkol. 1985;7(4):3-8. Eksp Onkol. 1985. PMID: 2994992 Review. Russian.